Danaher Corporation $DHR Shares Bought by Whittier Trust Co. of Nevada Inc.

Whittier Trust Co. of Nevada Inc. lifted its position in shares of Danaher Corporation (NYSE:DHR) by 6.1% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 133,764 shares of the conglomerate’s stock after buying an additional 7,647 shares during the quarter. Whittier Trust Co. of Nevada Inc.’s holdings in Danaher were worth $25,699,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also modified their holdings of DHR. Elevated Capital Advisors LLC acquired a new position in Danaher in the fourth quarter valued at $26,000. Hilton Head Capital Partners LLC acquired a new stake in Danaher in the 4th quarter worth about $27,000. JPL Wealth Management LLC acquired a new stake in Danaher in the 3rd quarter worth about $25,000. Clal Insurance Enterprises Holdings Ltd grew its holdings in Danaher by 71.6% in the 4th quarter. Clal Insurance Enterprises Holdings Ltd now owns 127 shares of the conglomerate’s stock valued at $29,000 after buying an additional 53 shares during the period. Finally, WFA of San Diego LLC acquired a new position in shares of Danaher during the 2nd quarter valued at about $26,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Analyst Ratings Changes

Several research analysts have recently weighed in on DHR shares. Wall Street Zen lowered shares of Danaher from a “buy” rating to a “hold” rating in a report on Saturday, April 25th. Royal Bank Of Canada initiated coverage on shares of Danaher in a report on Thursday, May 14th. They issued an “outperform” rating and a $200.00 target price for the company. UBS Group dropped their price target on shares of Danaher from $270.00 to $250.00 and set a “buy” rating for the company in a research report on Wednesday, April 22nd. Morgan Stanley decreased their price target on shares of Danaher from $270.00 to $255.00 and set an “overweight” rating on the stock in a report on Wednesday, April 22nd. Finally, Wolfe Research cut shares of Danaher from an “outperform” rating to a “peer perform” rating in a research note on Monday, June 1st. One analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating, four have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, Danaher currently has a consensus rating of “Moderate Buy” and a consensus price target of $233.61.

Danaher Price Performance

Danaher stock opened at $197.85 on Monday. Danaher Corporation has a 52-week low of $160.93 and a 52-week high of $242.80. The firm has a fifty day moving average of $179.01 and a 200-day moving average of $200.34. The firm has a market capitalization of $140.03 billion, a P/E ratio of 38.27, a PEG ratio of 2.52 and a beta of 0.79. The company has a quick ratio of 1.52, a current ratio of 1.87 and a debt-to-equity ratio of 0.33.

Danaher (NYSE:DHR) last posted its earnings results on Monday, April 20th. The conglomerate reported $2.06 earnings per share for the quarter, beating the consensus estimate of $1.94 by $0.12. Danaher had a net margin of 14.89% and a return on equity of 10.91%. The business had revenue of $5.95 billion for the quarter, compared to analyst estimates of $6 billion. During the same quarter in the previous year, the business posted $1.88 EPS. The business’s quarterly revenue was up 3.7% on a year-over-year basis. As a group, analysts predict that Danaher Corporation will post 8.44 EPS for the current year.

Danaher Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Friday, June 26th will be given a $0.40 dividend. The ex-dividend date of this dividend is Friday, June 26th. This represents a $1.60 annualized dividend and a dividend yield of 0.8%. Danaher’s dividend payout ratio is presently 30.95%.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.